1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Recurrent Pterygium: new trials by email Literature Review of Recurrent Pterygium trials Research Report on Recurrent Pterygium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection ziv-aflibercept - Neovascularization, Macular Degeneration | Phase 2 | Unknown | Rafic Hariri University Hospital | 100 | 2015-03-01 | 2018-08-29 |
| Subconjunctival Bevacizumab and Recurrent Pterygium Bevacizumab - Recurrent Pterygium | Phase 2 / Phase 3 | Completed | Instituto de Olhos de Goiania | 36 | 2012-02-01 | 2012-12-07 |
Pterygium (2) · Choroidal Neovascularization (1) · Diabetic Retinopathy (1) · Macular Degeneration (1) · Macular Edema (1) · Neovascularization, Pathologic (1) · Retinal Neovascularization (1) · Retinal Vein Occlusion (1)
Conjunctival Diseases (2) · Eye Diseases (2) · Cardiovascular Diseases (1) · Choroid Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1) · Metaplasia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Thrombosis (1)
Bevacizumab (1) · aflibercept (1)
Instituto de Olhos de Goiania (1) · Rafic Hariri University Hospital (1)
Brazil (1) · Lebanon (1)
Ahmad M Mansour, MD (1) · Larissa S Stival, MD (1)
PMID 25076364, PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432